Profile data is unavailable for this security.
About the company
Zhangzhou Pientzehuang Pharmaceutical Co Ltd is a China-based company mainly engaged in drug production and sales. The Company is also engaged in the production and sales of cosmetics and daily chemical products and the circulation of medicine. The Company's core products are PianZi Huang series products, including PianZi Huang, PianZi Huang capsule, compound PianZi Huang buccal tablets, compound PianZi Huang ointment, compound PianZi Huang hemorrhoids ointment and others, covering many fields such as liver disease medication, cold medication, dermatology medication. The Company's products are sold to domestic and overseas markets.
- Revenue in CNY (TTM)10.60bn
- Net income in CNY3.00bn
- Incorporated1999
- Employees2.79k
- LocationZhangzhou Pientzehuang Pharmaceutical Co LtdNo. 1 Hupo Road, Xiangcheng DistrictZHANGZHOU 363000ChinaCHN
- Phone+86 5 962301955
- Fax+86 5 962300313
- Websitehttps://www.zzpzh.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EBOS Group Ltd | 60.50bn | 1.23bn | 29.30bn | 5.20k | 23.65 | 2.58 | 15.17 | 0.4844 | 1.47 | 1.47 | 72.30 | 13.53 | 1.90 | 8.79 | 8.35 | 2,674,682.00 | 3.94 | 4.32 | 6.35 | 7.62 | 12.49 | 11.47 | 2.08 | 1.98 | 0.7358 | 6.79 | 0.4402 | 76.77 | 14.00 | 11.86 | 25.06 | 13.04 | 11.11 | 10.05 |
| Jointown Pharmaceutical Group Co Ltd | 148.52bn | 2.17bn | 32.01bn | 30.10k | 14.98 | 1.30 | -- | 0.2156 | 0.5469 | 0.5469 | 37.57 | 6.28 | 1.53 | 8.05 | 3.96 | 4,934,201.00 | 2.31 | 3.01 | 7.85 | 9.72 | 7.68 | 8.24 | 1.50 | 1.98 | 0.9782 | 3.50 | 0.5673 | 34.73 | 6.92 | 11.50 | 4.88 | 14.16 | -10.39 | 39.14 |
| China Resources Pharmaceutical Group Ltd | 244.95bn | 3.86bn | 34.23bn | 72.99k | 8.87 | 0.744 | 3.13 | 0.1397 | 0.664 | 0.664 | 42.15 | 7.92 | 1.06 | 7.06 | 3.84 | 3,628,502.00 | 3.36 | 3.02 | 12.72 | 11.35 | 15.67 | 15.72 | 3.18 | 2.87 | 1.09 | 8.70 | 0.412 | 24.73 | 12.16 | 8.86 | 10.11 | 2.80 | 13.58 | 7.05 |
| Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd | 76.83bn | 4.11bn | 49.86bn | 28.05k | 12.74 | 1.42 | -- | 0.6489 | 2.52 | 2.52 | 47.25 | 22.68 | 1.01 | 6.70 | 4.70 | 2,739,343.00 | 5.67 | 5.90 | 10.56 | 12.40 | 18.07 | 18.70 | 5.63 | 5.56 | 1.35 | -- | 0.3132 | 30.02 | 6.68 | 12.32 | 2.25 | 3.34 | 27.75 | 12.05 |
| Shanghai Pharmaceuticals Holding Co Ltd | 264.22bn | 3.79bn | 60.53bn | 48.16k | 17.55 | 0.9573 | -- | 0.2291 | 1.03 | 1.03 | 71.51 | 18.92 | 1.25 | 7.10 | 3.38 | 5,485,870.00 | 2.40 | 3.53 | 6.33 | 9.34 | 11.34 | 13.21 | 1.92 | 2.66 | 1.07 | 7.55 | 0.403 | 32.89 | 12.21 | 10.35 | -32.92 | -0.5896 | 8.86 | 0.00 |
| Sinopharm Group Co Ltd | 597.17bn | 9.06bn | 62.06bn | 115.96k | 6.85 | 0.8312 | 3.19 | 0.1039 | 3.14 | 3.14 | 206.89 | 25.87 | 1.59 | 9.06 | 3.72 | 5,567,788.00 | 4.01 | 4.09 | 16.32 | 17.37 | 8.13 | 8.54 | 2.52 | 2.55 | 1.15 | 6.48 | 0.3801 | 30.02 | 8.05 | 11.61 | 6.19 | 9.18 | -7.26 | 8.10 |
| Zhangzhou Pientzhng Phrmctcl Co Ltd | 10.60bn | 3.00bn | 143.50bn | 2.79k | 47.80 | 10.01 | -- | 13.54 | 4.98 | 4.98 | 17.57 | 23.76 | 0.6354 | 1.74 | 13.24 | 3,800,528.00 | 18.30 | 18.82 | 22.61 | 23.91 | 45.77 | 46.55 | 28.81 | 27.98 | 4.02 | -- | 0.0898 | 36.49 | 15.69 | 16.11 | 13.15 | 19.60 | 13.83 | 31.06 |
| Cardinal Health Inc | 1.59tn | 3.99bn | 175.19bn | 48.00k | 44.10 | -- | 19.35 | 0.1099 | 2.26 | 2.26 | 885.83 | -13.38 | 4.94 | 12.58 | 19.56 | 4,595,250.00 | 1.24 | -1.13 | 5.41 | -3.08 | 3.35 | 4.00 | 0.2507 | -0.2816 | 0.5084 | 29.96 | 2.26 | -- | 13.04 | 8.43 | 127.97 | -- | 4.61 | 1.40 |
| Cencora Inc | 2.00tn | 13.39bn | 323.74bn | 42.00k | 24.57 | 41.35 | 15.08 | 0.162 | 9.14 | 9.14 | 1,364.32 | 5.43 | 4.51 | 15.45 | 12.34 | 6,584,203.00 | 3.02 | 0.9542 | 13.51 | 3.95 | 3.40 | 3.14 | 0.6699 | 0.2178 | 0.5331 | 12.61 | 0.8105 | 76.85 | 9.89 | 9.32 | 2.74 | 10.79 | 6.38 | 5.00 |
| McKesson Corp | 2.23tn | 21.69bn | 526.03bn | 45.00k | 25.04 | -- | 19.18 | 0.2356 | 22.36 | 22.36 | 2,303.89 | -15.16 | 4.76 | 14.52 | 15.06 | 6,865,578.00 | 4.87 | 1.57 | 22.01 | 6.03 | 4.07 | 4.74 | 1.02 | 0.3764 | 0.5125 | 15.05 | 1.40 | 36.01 | 11.65 | 7.59 | -15.75 | -- | 4.28 | 9.71 |
Data as of Mar 13 2024. Currency figures normalised to Zhangzhou Pientzehuang Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
5.76%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2023 | 10.77m | 1.79% |
| E Fund Management Co., Ltd.as of 31 Dec 2023 | 5.56m | 0.92% |
| China Asset Management Co., Ltd.as of 31 Dec 2023 | 3.43m | 0.57% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2023 | 3.27m | 0.54% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2023 | 3.18m | 0.53% |
| GF Fund Management Co., Ltd.as of 30 Jun 2023 | 2.90m | 0.48% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 1.65m | 0.27% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2023 | 1.57m | 0.26% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2023 | 1.48m | 0.25% |
| First Seafront Fund Management Co., Ltd.as of 30 Jun 2023 | 961.22k | 0.16% |
More ▼
Data from 30 Jun 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.
